(Q48867951)

16 February 2018

editorial

0 references

title

Inhibitors of quinolinic acid synthesis: new weapons in the study of neuroinflammatory diseases. (English)

1 reference

16 February 2018

author name string

Gabriele Costantino

series ordinal

1

1 reference

16 February 2018

publication date

1 May 2014

1 reference

16 February 2018

Future Medicinal Chemistry

published in

1 reference

16 February 2018

volume

6

1 reference

16 February 2018

issue

8

1 reference

16 February 2018

page(s)

841-843

1 reference

16 February 2018

An expanding range of targets for kynurenine metabolites of tryptophan

cites work

1 reference

Kynurenines in the mammalian brain: when physiology meets pathology

21 January 2018

1 reference

Quinolinic acid, the inescapable neurotoxin

21 January 2018

1 reference

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

21 January 2018

1 reference

Differential vulnerability of central neurons of the rat to quinolinic acid

21 January 2018

1 reference

Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system

21 January 2018

1 reference

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

21 January 2018

1 reference

Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease

21 January 2018

1 reference

On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo

21 January 2018

1 reference

Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase

21 January 2018

1 reference

Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase

21 January 2018

1 reference

The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation

21 January 2018

1 reference

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

21 January 2018

1 reference

The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress

21 January 2018

1 reference

2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.14.35

1 reference

16 February 2018

1 reference

16 February 2018